NLRP3 and Hepatic fibrosis: The current study provides compelling evidence that the combined administration of PFD and LIR enhances the regenerative response, normalizes Beclin-1 expression, and modulates the NLRP3 inflammasome pathway, thereby alleviating liver fibrosis (LF) (Fig. 7).